{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:55:30Z","timestamp":1782888930429,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Most previous studies on the efficacy of antipsychotic medication for the treatment of delirium have reported that there is no significant difference between typical and atypical antipsychotic medications. It is known, however, that older age might be a predictor of poor response to antipsychotics in the treatment of delirium. The objective of this study was to compare the efficacy and safety of haloperidol versus three atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) for the treatment of delirium with consideration of patient age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study was a 6-day, prospective, comparative clinical observational study of haloperidol versus atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in patients with delirium at a tertiary level hospital. The subjects were referred to the consultation-liaison psychiatric service for management of delirium and were screened before enrollment in this study. A total of 80 subjects were assigned to receive either haloperidol (N\u2009=\u200923), risperidone (N\u2009=\u200921), olanzapine (N\u2009=\u200918), or quetiapine (N\u2009=\u200918). The efficacy was evaluated using the Korean version of the Delirium Rating Scale-Revised-98 (DRS-K) and the Korean version of the Mini Mental Status Examination (K-MMSE). The safety was evaluated by the Udvalg Kliniske Undersogelser side effect rating scale.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were no significant differences in mean DRS-K severity or K-MMSE scores among the four groups at baseline. In all groups, the DRS-K severity score decreased and the K-MMSE score increased significantly over the study period. However, there were no significant differences in the improvement of DRS-K or K-MMSE scores among the four groups. Similarly, cognitive and non-cognitive subscale DRS-K scores decreased regardless of the treatment group. The treatment response rate was lower in patients over 75 years old than in patients under 75 years old. Particularly, the response rate to olanzapine was poorer in the older age group. Fifteen subjects experienced a few adverse events, but there were no significant differences in adverse event profiles among the four groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Haloperidol, risperidone, olanzapine, and quetiapine were equally efficacious and safe in the treatment of delirium. However, age is a factor that needs to be considered when making a choice of antipsychotic medication for the treatment of delirium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinical Research Information Service, Republic of Korea, (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/cris.nih.go.kr\/cris\/en\/search\/basic_search.jsp\" ext-link-type=\"uri\">http:\/\/cris.nih.go.kr\/cris\/en\/search\/basic_search.jsp<\/jats:ext-link>, Registered Trial No. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/cris.nih.go.kr\/cris\/en\/search\/search_result_st01.jsp?seq=2689\" ext-link-type=\"uri\">KCT0000632<\/jats:ext-link>).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-13-240","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T07:01:53Z","timestamp":1380524513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium"],"prefix":"10.1186","volume":"13","author":[{"given":"Hyung-Jun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ho","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"issue":"11","key":"1416_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","volume":"275","author":"SK Inouye","year":"1996","unstructured":"Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA. 1996, 275 (11): 852-857. 10.1001\/jama.1996.03530350034031.","journal-title":"JAMA"},{"issue":"4","key":"1416_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0749-0690(18)30089-2","volume":"14","author":"SK Inouye","year":"1998","unstructured":"Inouye SK: Delirium in hospitalized older patients. Clin Geriatr Med. 1998, 14 (4): 745-764.","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"1416_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrneurol.2009.24","volume":"5","author":"TG Fong","year":"2009","unstructured":"Fong TG, Tulebaev SR, Inouye SK: Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009, 5 (4): 210-220. 10.1038\/nrneurol.2009.24.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1416_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archinte.1995.00430050035004","volume":"155","author":"CB Dyer","year":"1995","unstructured":"Dyer CB, Ashton CM, Teasdale TA: Postoperative delirium: a review of 80 primary data-collection studies. Arch Intern Med. 1995, 155 (5): 461-465. 10.1001\/archinte.1995.00430050035004.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1416_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0002-9343(98)00292-7","volume":"105","author":"ER Marcantonio","year":"1998","unstructured":"Marcantonio ER, Goldman L, Orav EJ, Cook EF, Lee TH: The association of intraoperative factors with the development of postoperative delirium. Am J Med. 1998, 105 (5): 380-384. 10.1016\/S0002-9343(98)00292-7.","journal-title":"Am J Med"},{"issue":"5","key":"1416_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.0.CO;2-2","volume":"78","author":"H Minagawa","year":"1996","unstructured":"Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K: Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer. 1996, 78 (5): 1131-1137. 10.1002\/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.0.CO;2-2.","journal-title":"Cancer"},{"issue":"4","key":"1416_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#","volume":"79","author":"J Pereira","year":"1997","unstructured":"Pereira J, Hanson J, Bruera E: The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997, 79 (4): 835-842. 10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#.","journal-title":"Cancer"},{"issue":"6","key":"1416_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/archinte.160.6.786","volume":"160","author":"PG Lawlor","year":"2000","unstructured":"Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED: Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000, 160 (6): 786-794. 10.1001\/archinte.160.6.786.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1416_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jnnp.2003.023366","volume":"75","author":"A Burns","year":"2004","unstructured":"Burns A, Gallagley A, Byrne J: Delirium. J Neurol Neurosur Ps. 2004, 75 (3): 362-367. 10.1136\/jnnp.2003.023366.","journal-title":"J Neurol Neurosur Ps"},{"issue":"4","key":"1416_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.genhosppsych.2011.05.001","volume":"33","author":"G Jain","year":"2011","unstructured":"Jain G, Chakrabarti S, Kulhara P: Symptoms of delirium: an exploratory factor analytic study among referred patients. Gen Hosp Psychiatry. 2011, 33 (4): 377-385. 10.1016\/j.genhosppsych.2011.05.001.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"1416_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpsychores.2008.05.020","volume":"65","author":"N Gupta","year":"2008","unstructured":"Gupta N, de Jonghe J, Schieveld J, Leonard M, Meagher D: Delirium phenomenology: what can we learn from the symptoms of delirium?. J Psychosom Res. 2008, 65 (3): 215-222. 10.1016\/j.jpsychores.2008.05.020.","journal-title":"J Psychosom Res"},{"issue":"13","key":"1416_CR12","first-page":"1789","volume":"258","author":"ZJ Lipowski","year":"1987","unstructured":"Lipowski ZJ: Delirium (acute confusional states). JAMA (Chicago, Ill). 1987, 258 (13): 1789-1792.","journal-title":"JAMA (Chicago, Ill)"},{"issue":"11","key":"1416_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra052321","volume":"354","author":"SK Inouye","year":"2006","unstructured":"Inouye SK: Delirium in older persons. N Engl J Med. 2006, 354 (11): 1157-1165. 10.1056\/NEJMra052321.","journal-title":"N Engl J Med"},{"issue":"14","key":"1416_CR14","first-page":"1753","volume":"291","author":"EW Ely","year":"2004","unstructured":"Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, Inouye SK, Bernard GR, Dittus RS: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA (Chicago, Ill). 2004, 291 (14): 1753-1762.","journal-title":"JAMA (Chicago, Ill)"},{"issue":"11","key":"1416_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1046\/j.1532-5415.2003.51509.x","volume":"51","author":"J McCusker","year":"2003","unstructured":"McCusker J, Cole MG, Dendukuri N, Belzile E: Does delirium increase hospital stay?. J Am Geriatr Soc. 2003, 51 (11): 1539-1546. 10.1046\/j.1532-5415.2003.51509.x.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1416_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/ageing\/afl005","volume":"35","author":"N Siddiqi","year":"2006","unstructured":"Siddiqi N, House AO, Holmes JD: Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006, 35 (4): 350-364. 10.1093\/ageing\/afl005.","journal-title":"Age Ageing"},{"issue":"3","key":"1416_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpsychores.2008.05.024","volume":"65","author":"J Kean","year":"2008","unstructured":"Kean J, Ryan K: Delirium detection in clinical practice and research: critique of current tools and suggestions for future development. J Psychosom Res. 2008, 65 (3): 255-259. 10.1016\/j.jpsychores.2008.05.024.","journal-title":"J Psychosom Res"},{"issue":"3","key":"1416_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s11920-008-0040-3","volume":"10","author":"C Pae","year":"2008","unstructured":"Pae C, Marks DM, Han C, Patkar A, Masand P: Delirium: where do we stand?. Curr Psychiatry Rep. 2008, 10 (3): 240-248. 10.1007\/s11920-008-0040-3.","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"1416_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1345\/aph.1H241","volume":"40","author":"H Lacasse","year":"2006","unstructured":"Lacasse H, Perreault M, Williamson DR: Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother. 2006, 40 (11): 1966-1973. 10.1345\/aph.1H241.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1416_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-0031-1273759","volume":"44","author":"S Grover","year":"2011","unstructured":"Grover S, Mattoo SK, Gupta N: Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review. Pharmacopsychiatry. 2011, 44 (2): 43-54. 10.1055\/s-0031-1273759.","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"1416_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jamda.2007.08.007","volume":"9","author":"LB Ozbolt","year":"2008","unstructured":"Ozbolt LB, Paniagua MA, Kaiser RM: Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc. 2008, 9 (1): 18-28. 10.1016\/j.jamda.2007.08.007.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1416_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004714-199304000-00007","volume":"13","author":"E Metzger","year":"1993","unstructured":"Metzger E, Friedman R: Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol. 1993, 13 (2): 128-132.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"1416_CR23","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","volume":"158","author":"AH Glassman","year":"2001","unstructured":"Glassman AH, Bigger JT: Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001, 158 (11): 1774-1782. 10.1176\/appi.ajp.158.11.1774.","journal-title":"Am J Psychiatry"},{"key":"1416_CR24","first-page":"535","volume-title":"Acute extrapyramidal syndrome","author":"D Casey","year":"1995","unstructured":"Casey D: Acute extrapyramidal syndrome. 1995, Washington, DC: Contemporary Use in the Treatement of Schizophrenia American Psychiatric Press, 535-550."},{"issue":"24","key":"1416_CR25","first-page":"2898","volume":"300","author":"W Breitbart","year":"2008","unstructured":"Breitbart W, Alici Y: Agitation and delirium at the end of life: \u201cWe couldn\u2019t manage him\u201d. JAMA (Chicago, Ill). 2008, 300 (24): 2898-2910. E2891","journal-title":"JAMA (Chicago, Ill)"},{"issue":"4","key":"1416_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/hup.1117","volume":"25","author":"J Yoo","year":"2010","unstructured":"Yoo J, Lee S, Kim S, Bae K, Yang S, Kim J, Shin I, Yoon J: Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharm. 2010, 25 (4): 298-302. 10.1002\/hup.1117.","journal-title":"Hum Psychopharm"},{"issue":"3","key":"1416_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1176\/appi.psy.43.3.171","volume":"43","author":"TL Schwartz","year":"2002","unstructured":"Schwartz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics. 2002, 43 (3): 171-174. 10.1176\/appi.psy.43.3.171.","journal-title":"Psychosomatics"},{"issue":"3","key":"1416_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00134-003-2117-0","volume":"30","author":"YK Skrobik","year":"2004","unstructured":"Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium in a critical care setting. Intens Care Med. 2004, 30 (3): 444-449. 10.1007\/s00134-003-2117-0.","journal-title":"Intens Care Med"},{"issue":"2","key":"1416_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/hup.559","volume":"19","author":"CU Pae","year":"2004","unstructured":"Pae CU, Lee SJ, Lee CU, Lee C, Paik IH: A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol. 2004, 19 (2): 125-127. 10.1002\/hup.559.","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"1416_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1440-1819.2009.02002.x","volume":"63","author":"V Peritogiannis","year":"2009","unstructured":"Peritogiannis V, Stefanou E, Lixouriotis C, Gkogkos C, Rizos DV: Atypical antipsychotics in the treatment of delirium. Psychiat Clin Neuros. 2009, 63 (5): 623-631. 10.1111\/j.1440-1819.2009.02002.x.","journal-title":"Psychiat Clin Neuros"},{"issue":"3","key":"1416_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jpsychores.2008.05.025","volume":"65","author":"RS Bourne","year":"2008","unstructured":"Bourne RS, Tahir TA, Borthwick M, Sampson EL: Drug treatment of delirium: past, present and future. J Psychosom Res. 2008, 65 (3): 273-282. 10.1016\/j.jpsychores.2008.05.025.","journal-title":"J Psychosom Res"},{"issue":"4","key":"1416_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jpsychores.2011.01.019","volume":"71","author":"S Grover","year":"2011","unstructured":"Grover S, Kumar V, Chakrabarti S: Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res. 2011, 71 (4): 277-281. 10.1016\/j.jpsychores.2011.01.019.","journal-title":"J Psychosom Res"},{"issue":"5","key":"1416_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jpsychores.2010.05.006","volume":"69","author":"TA Tahir","year":"2010","unstructured":"Tahir TA, Eeles E, Karapareddy V, Muthuvelu P, Chapple S, Phillips B, Adyemo T, Farewell D, Bisson JI: A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res. 2010, 69 (5): 485-490. 10.1016\/j.jpsychores.2010.05.006.","journal-title":"J Psychosom Res"},{"issue":"2","key":"1416_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","volume":"38","author":"JW Devlin","year":"2010","unstructured":"Devlin JW, Roberts RJ, Fong J, Skrobik Y, Riker R, Hill NS, Robbins T, Garpestad E: Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010, 38 (2): 419-427. 10.1097\/CCM.0b013e3181b9e302.","journal-title":"Crit Care Med"},{"issue":"2","key":"1416_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1440-1819.2005.01355.x","volume":"59","author":"J Kim","year":"2005","unstructured":"Kim J, Jung I, Han C, Cho S, Kim L, Kim S, Lee B, Lee H, Kim Y: Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiat Clin Neuros. 2005, 59 (2): 183-188. 10.1111\/j.1440-1819.2005.01355.x.","journal-title":"Psychiat Clin Neuros"},{"issue":"4","key":"1416_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0033-3182(04)70170-X","volume":"45","author":"C Han","year":"2004","unstructured":"Han C, Kim Y: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004, 45 (4): 297-301. 10.1016\/S0033-3182(04)70170-X.","journal-title":"Psychosomatics"},{"issue":"6","key":"1416_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00004850-200511000-00005","volume":"20","author":"K Lee","year":"2005","unstructured":"Lee K, Won W, Lee H, Kweon Y, Lee CT, Pae C, Bahk W: Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharm. 2005, 20 (6): 311-314. 10.1097\/00004850-200511000-00005.","journal-title":"Int Clin Psychopharm"},{"key":"1416_CR38","first-page":"1234","volume":"8","author":"H Hu","year":"2004","unstructured":"Hu H, Deng W, Yang H: A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongqing Med J. 2004, 8: 1234-1237.","journal-title":"Chongqing Med J"},{"issue":"42","key":"1416_CR39","first-page":"188","volume":"10","author":"H Hu","year":"2006","unstructured":"Hu H, Deng W, Yang H, Liu Y: Olanzapine and haloperidol for senile delirium: a randomized controlled observation. Chinese J Clin Rehabil. 2006, 10 (42): 188-190.","journal-title":"Chinese J Clin Rehabil"},{"issue":"3","key":"1416_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1176\/appi.psy.43.3.175","volume":"43","author":"W Breitbart","year":"2002","unstructured":"Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics. 2002, 43 (3): 175-182. 10.1176\/appi.psy.43.3.175.","journal-title":"Psychosomatics"},{"issue":"11","key":"1416_CR41","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1176\/appi.ajp.161.11.2050","volume":"161","author":"SP Roose","year":"2004","unstructured":"Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiat. 2004, 161 (11): 2050-2059. 10.1176\/appi.ajp.161.11.2050.","journal-title":"Am J Psychiat"},{"issue":"3","key":"1416_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/JGP.0b013e3181bf9edd","volume":"18","author":"S Cheng","year":"2010","unstructured":"Cheng S, Yu EC, Lee SY, Wong JY, Lau KH, Chan LK, Chan H: The geriatric depression scale as a screening tool for depression and suicide ideation: a replication and extention. Am J Geriat Psychiat. 2010, 18 (3): 256-265. 10.1097\/JGP.0b013e3181bf9edd.","journal-title":"Am J Geriat Psychiat"},{"issue":"1","key":"1416_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.archger.2011.02.011","volume":"54","author":"A Paraschakis","year":"2012","unstructured":"Paraschakis A, Douzenis A, Michopoulos I, Christodoulou C, Vassilopoulou K, Koutsaftis F, Lykouras L: Late onset suicide: distinction between \u201cyoung-old\u201d vs. \u201cold-old\u201d suicide victims. How different populations are they?. Arch Gerontol Geriat. 2012, 54 (1): 136-139. 10.1016\/j.archger.2011.02.011.","journal-title":"Arch Gerontol Geriat"},{"key":"1416_CR44","volume-title":"Cochrane Database Syst Rev","author":"E Lonergan","year":"2007","unstructured":"Lonergan E, Britton AM, Luxenberg J, Wyller T: Antipsychotics for delirium. Cochrane Database Syst Rev. 2007, 2: CD005594"},{"key":"1416_CR45","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV","year":"2000","unstructured":"American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV: Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 2000, Washington, DC: American Psychiatric Association, 4","edition":"4"},{"key":"1416_CR46","volume-title":"The American psychiatric publishing textbook of neuropsychiatry and behavioral neurosciences","author":"SC Yudofsky","year":"2008","unstructured":"Yudofsky SC, Hales RE, American Psychiatric Publishing: The American psychiatric publishing textbook of neuropsychiatry and behavioral neurosciences. 2008, Washington, DC: American Psychiatric Pub, 5","edition":"5"},{"issue":"1","key":"1416_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S1041610211001815","volume":"24","author":"S Grover","year":"2012","unstructured":"Grover S, Kate N, Agarwal M, Mattoo SK, Avasthi A, Malhotra S, Kulhara P, Chakrabarti S, Basu D: Delirium in elderly people: a study of a psychiatric liaison service in north India. Int Psychogeriatr. 2012, 24 (1): 117-127. 10.1017\/S1041610211001815.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1416_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4306\/pi.2011.8.1.30","volume":"8","author":"Y Lee","year":"2011","unstructured":"Lee Y, Ryu J, Lee J, Kim H, Shin IH, Kim J, Trzepacz PT: Korean version of the delirium rating scale-revised-98: reliability and validity. Psychiat Invest. 2011, 8 (1): 30-38. 10.4306\/pi.2011.8.1.30.","journal-title":"Psychiat Invest"},{"issue":"2","key":"1416_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/jnp.13.2.229","volume":"13","author":"PT Trzepacz","year":"2001","unstructured":"Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N: Validation of the delirium rating scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsych Clin N. 2001, 13 (2): 229-242. 10.1176\/appi.neuropsych.13.2.229.","journal-title":"J Neuropsych Clin N"},{"issue":"6","key":"1416_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpsychores.2011.06.001","volume":"71","author":"DJ Meagher","year":"2011","unstructured":"Meagher DJ, Leonard M, Donnelly S, Conroy M, Adamis D, Trzepacz PT: A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis. J Psychosom Res. 2011, 71 (6): 395-403. 10.1016\/j.jpsychores.2011.06.001.","journal-title":"J Psychosom Res"},{"issue":"2","key":"1416_CR51","first-page":"300","volume":"15","author":"YND Kang","year":"1997","unstructured":"Kang YND, Hahn S: A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997, 15 (2): 300-308.","journal-title":"J Korean Neurol Assoc"},{"issue":"3","key":"1416_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975, 12 (3): 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiat Res"},{"key":"1416_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987, 334: 1-100.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1416_CR54","volume-title":"Applied mixed models in medicine","author":"H Brown","year":"1999","unstructured":"Brown H, Prescott R: Applied mixed models in medicine. 1999, Chichester: Wiley"},{"issue":"1","key":"1416_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/09540260802675346","volume":"21","author":"D Adamis","year":"2009","unstructured":"Adamis D: Statistical methods for analysing longitudinal data in delirium studies. Int Rev Psychiatry. 2009, 21 (1): 74-85. 10.1080\/09540260802675346.","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"1416_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0891988705277535","volume":"18","author":"D Adamis","year":"2005","unstructured":"Adamis D, Morrison C, Treloar A, Macdonald AJ, Martin FC: The performance of the clock drawing test in elderly medical inpatients: does it have utility in the identification of delirium?. J Geriatr Psychiatry Neurol. 2005, 18 (3): 129-133. 10.1177\/0891988705277535.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"1416_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00004850-200405000-00008","volume":"19","author":"C Liu","year":"2004","unstructured":"Liu C, Juang Y, Liang H, Lin N, Yeh E: Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharm. 2004, 19 (3): 165-168. 10.1097\/00004850-200405000-00008.","journal-title":"Int Clin Psychopharm"},{"issue":"1","key":"1416_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4088\/PCC.v02n0103","volume":"2","author":"TL Schwartz","year":"2000","unstructured":"Schwartz TL, Masand PS: Treatment of delirium with Quetiapine. Prim Care Companion J Clin Psychiat. 2000, 2 (1): 10-12. 10.4088\/PCC.v02n0103.","journal-title":"Prim Care Companion J Clin Psychiat"},{"issue":"5","key":"1416_CR59","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0033-3182(98)71301-5","volume":"39","author":"A Sipahimalani","year":"1998","unstructured":"Sipahimalani A, Masand PS: Olanzapine in the treatment of delirium. Psychosomatics. 1998, 39 (5): 422-430. 10.1016\/S0033-3182(98)71301-5.","journal-title":"Psychosomatics"},{"issue":"11","key":"1416_CR60","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4088\/JCP.v64n1106","volume":"64","author":"Y Sasaki","year":"2003","unstructured":"Sasaki Y, Matsuyama T, Inoue S, Sunami T, Inoue T, Denda K, Koyama T: A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiat. 2003, 64 (11): 1316-1321. 10.4088\/JCP.v64n1106.","journal-title":"J Clin Psychiat"},{"issue":"2","key":"1416_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1479-8301.2003.00012.x","volume":"3","author":"K Omura","year":"2003","unstructured":"Omura K, Amano N: Clinical experience of quetiapine in 24 elderly patients with delirium. Psychogeriatrics. 2003, 3 (2): 69-72. 10.1046\/j.1479-8301.2003.00012.x.","journal-title":"Psychogeriatrics"},{"issue":"1","key":"1416_CR62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/070674370505000117","volume":"50","author":"N Gupta","year":"2005","unstructured":"Gupta N, Sharma P, Mattoo SK: Effectiveness of risperidone in delirium. Can J Psychiat. 2005, 50 (1): 75-75.","journal-title":"Can J Psychiat"},{"issue":"4","key":"1416_CR63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1532-5415.2005.53210.x","volume":"53","author":"M Lundstrom","year":"2005","unstructured":"Lundstrom M, Edlund A, Karlsson S, Brannstrom B, Bucht G, Gustafson Y: A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc. 2005, 53 (4): 622-628. 10.1111\/j.1532-5415.2005.53210.x.","journal-title":"J Am Geriatr Soc"},{"key":"1416_CR64","volume-title":"Kaplan & Sadock\u2019s synopsis of psychiatry: behavioral sciences\/clinical psychiatry","author":"BJ Sadock","year":"2007","unstructured":"Sadock BJ, Kaplan HI, Sadock VA: Kaplan & Sadock\u2019s synopsis of psychiatry: behavioral sciences\/clinical psychiatry. 2007, Philadelphia: Wolter Kluwer\/Lippincott Williams & Wilkins, 10","edition":"10"},{"issue":"13","key":"1416_CR65","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1503\/cmaj.1041064","volume":"172","author":"DM Gardner","year":"2005","unstructured":"Gardner DM, Baldessarini RJ, Waraich P: Modern antipsychotic drugs: a critical overview. Can Med Assoc J; CMAJ. 2005, 172 (13): 1703-1711. 10.1503\/cmaj.1041064.","journal-title":"Can Med Assoc J; CMAJ"},{"issue":"1\u20133","key":"1416_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2006.07.011","volume":"88","author":"ML Chew","year":"2006","unstructured":"Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies R, Kapur S, Gharabawi G: A model of anticholinergic activity of atypical antipsychotic medications. Schizophrenia Res. 2006, 88 (1\u20133): 63-72.","journal-title":"Schizophrenia Res"},{"key":"1416_CR67","volume-title":"Geriatrics syllabus for specialists","author":"PR Katz","year":"2002","unstructured":"Katz PR, Grossberg GT, Potter JF, Solomon DH: Geriatrics syllabus for specialists. 2002, New York: American Geriatrics Society"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-240\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:29:52Z","timestamp":1630546192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-240","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]},"assertion":[{"value":"11 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"240"}}